Notice: This CMS-approved document has been submitted - Philips ...
Notice: This CMS-approved document has been submitted - Philips ... Notice: This CMS-approved document has been submitted - Philips ...
CMS-1403-FC e-prescribing in physicians’ offices is resource intensive and many local pharmacies are not prepared to use e- prescribing. Response: As described above, the MIPPA requires us to implement an incentive payment for successful electronic prescribers beginning in 2009. Many of the MIPPA requirements with respect to the incentive payment for successful electronic prescribers are generally self- implementing, require little exercise of discretion, and build on existing aspects of the PQRI that have already been proposed. In addition, although section 1848(m)(5)(C) of the Act, as redesignated and amended by the MIPPA, authorizes us to implement certain aspects of the 2009 e- prescribing incentive program by program instruction or otherwise, we are finalizing this program for 2009 in this final rule with comment period. The quality measure that we are using to determine whether an eligible professional qualifies as a successful electronic prescriber was available for public comment during its development by QIP as well as during the consensus process for AQA adoption and NQF endorsement, both of which have been achieved. Additionally, as this quality measure was one of the quality measures proposed for the 2009 PQRI in the CY 2009 PFS proposed rule, the public had an opportunity to comment 702
CMS-1403-FC on this quality measure during the proposed rule’s comment period. Comment: One commenter was concerned that future DEA regulation changes may complicate e-prescribing. The commenter urged us to exempt e-prescribing of controlled substances from any assessment of differential payments. Response: We are aware of the proposed DEA regulation changes and believe the modification and explanation of the third G code described above adequately addresses this issue. Comment: We received one comment that emergency department evaluation and management codes do not appear in the denominator of the e-prescribing measure proposed for the 2009 PQRI (Measure #125). Another commenter suggested that we maintain the eye visit codes in this measure so that ophthalmologists can participate in the e-prescribing incentive program. Response: We have addressed in the body of the preamble the comment with respect to hospital based services of professionals. The current measure specifications contain office and outpatient codes applying to eye care. As stated above, we will post the final specifications for the e-prescribing measure for purposes 703
- Page 651 and 652: CMS-1403-FC Measure Title Measure S
- Page 653 and 654: CMS-1403-FC proposed HIV/AIDS measu
- Page 655 and 656: CMS-1403-FC set of denominator spec
- Page 657 and 658: CMS-1403-FC results, for this purpo
- Page 659 and 660: CMS-1403-FC informed decision-makin
- Page 661 and 662: CMS-1403-FC Comment: Several commen
- Page 663 and 664: CMS-1403-FC prior commitments that
- Page 665 and 666: CMS-1403-FC groups who successfully
- Page 667 and 668: CMS-1403-FC ● Eligible profession
- Page 669 and 670: CMS-1403-FC patients, families, and
- Page 671 and 672: CMS-1403-FC that have satisfactoril
- Page 673 and 674: CMS-1403-FC e-prescribing quality m
- Page 675 and 676: CMS-1403-FC Douglas S. and Friedman
- Page 677 and 678: CMS-1403-FC subsequent year, if the
- Page 679 and 680: CMS-1403-FC eligible professional f
- Page 681 and 682: CMS-1403-FC and is included in the
- Page 683 and 684: CMS-1403-FC The measure becomes app
- Page 685 and 686: CMS-1403-FC is, Measure #125) appli
- Page 687 and 688: CMS-1403-FC outpatient setting. Whi
- Page 689 and 690: CMS-1403-FC ability of an electroni
- Page 691 and 692: CMS-1403-FC October 2005 (hereinaft
- Page 693 and 694: CMS-1403-FC We are aware that there
- Page 695 and 696: CMS-1403-FC provided during the enc
- Page 697 and 698: CMS-1403-FC denominator of a measur
- Page 699 and 700: CMS-1403-FC cases. If the is determ
- Page 701: CMS-1403-FC during 2009; and (3) wh
- Page 705 and 706: CMS-1403-FC become effective until
- Page 707 and 708: CMS-1403-FC and CY 2007 PFS final r
- Page 709 and 710: CMS-1403-FC directly affected by th
- Page 711 and 712: CMS-1403-FC requires advanced pract
- Page 713 and 714: CMS-1403-FC applaud CMS for recogni
- Page 715 and 716: CMS-1403-FC standardization of DNP
- Page 717 and 718: CMS-1403-FC for the most part, been
- Page 719 and 720: CMS-1403-FC that the requirement fo
- Page 721 and 722: CMS-1403-FC degree in radiologic te
- Page 723 and 724: CMS-1403-FC the physicians that fur
- Page 725 and 726: CMS-1403-FC is associated with a te
- Page 727 and 728: CMS-1403-FC facility in which a tec
- Page 729 and 730: CMS-1403-FC by the Medicare program
- Page 731 and 732: CMS-1403-FC pressure (CPAP)” and
- Page 733 and 734: CMS-1403-FC for example chronic obs
- Page 735 and 736: CMS-1403-FC thus they believe leadi
- Page 737 and 738: CMS-1403-FC Excepting attended faci
- Page 739 and 740: CMS-1403-FC supplier separately. Ho
- Page 741 and 742: CMS-1403-FC final rule’s provisio
- Page 743 and 744: CMS-1403-FC as a DME supplier and p
- Page 745 and 746: CMS-1403-FC Moreover, given our gen
- Page 747 and 748: CMS-1403-FC resources and infrastru
- Page 749 and 750: CMS-1403-FC Comment: Several commen
- Page 751 and 752: CMS-1403-FC organization through a
<strong>CMS</strong>-1403-FC<br />
e-prescribing in physicians’ offices is resource intensive<br />
and many local pharmacies are not prepared to use e-<br />
prescribing.<br />
Response: As described above, the MIPPA requires us to<br />
implement an incentive payment for successful electronic<br />
prescribers beginning in 2009. Many of the MIPPA<br />
requirements with respect to the incentive payment for<br />
successful electronic prescribers are generally self-<br />
implementing, require little exercise of discretion, and<br />
build on existing aspects of the PQRI that have already<br />
<strong>been</strong> proposed. In addition, although section 1848(m)(5)(C)<br />
of the Act, as redesignated and amended by the MIPPA,<br />
authorizes us to implement certain aspects of the 2009 e-<br />
prescribing incentive program by program instruction or<br />
otherwise, we are finalizing this program for 2009 in this<br />
final rule with comment period. The quality measure that<br />
we are using to determine whether an eligible professional<br />
qualifies as a successful electronic prescriber was<br />
available for public comment during its development by QIP<br />
as well as during the consensus process for AQA adoption<br />
and NQF endorsement, both of which have <strong>been</strong> achieved.<br />
Additionally, as this quality measure was one of the<br />
quality measures proposed for the 2009 PQRI in the CY 2009<br />
PFS proposed rule, the public had an opportunity to comment<br />
702